Evidence map›Paper›PMID 34522056›Full record

ArticleNational Academy science letters. National Academy of Sciences, India2022

COVID-19 Vaccines: Speedy Development and their Use to be Saviour of Humanity.

V P Kamboj

Abstract readNews
In one paragraph

Article in National Academy science letters. National Academy of Sciences, India, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

V P KambojCSIR-CDRI: CSIR-Central Drug Research Institute and Biotech Park, Lucknow, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 disease is caused by a novel coronavirus (SARS-CoV-2), and it was declared as a pandemic by WHO within two and half months of detection of first case. The pandemic situation induced unprecedented cooperation amongst countries, academia, public sector institutions and industry in sharing knowledge, resources and strategies. In this article, development of vaccines and their delivery system is discussed. The regulatory toxicology and clinical trials are the most important factors to ensure safety and formation of neutralizing antibodies for efficacy. The article creates awareness about the global cooperation and efforts in developing the vaccines speedily for the society. Finally, results show that all the COVID-19 vaccines trigger an immune response to enable your body to fight and kill virus and none of them cause COVID-19 disease.

Indexed as

Coronavirus (SARS-CoV-2)Delivery systemGlobal cooperationHerd immunitymRNA vaccinesSpeedy developmentVaccine

Identifiers

PMID34522056
PMCPMC8428499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.